Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Safety, Tolerability, and Pharmacokinetics of an Oral Withania Somnifera Product in Older Adults
Authors not listed
Oregon Health and Science University · 2024
Abstract
This study will measure the oral bioavailability and pharmacokinetics of known compounds from a standardized Withania somnifera botanical dietary supplement in healthy older adults.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-05-29 MST
Cite this
APA
Anonymous. (2024). Safety, Tolerability, and Pharmacokinetics of an Oral Withania Somnifera Product in Older Adults. <em>Oregon Health and Science University</em>. https://clinicaltrials.gov/study/NCT06171724
Vancouver
Anonymous. Safety, Tolerability, and Pharmacokinetics of an Oral Withania Somnifera Product in Older Adults. Oregon Health and Science University. 2024.
BibTeX
@misc{anon2024Safety,
title = {Safety, Tolerability, and Pharmacokinetics of an Oral Withania Somnifera Product in Older Adults},
author = {Anonymous},
journal = {Oregon Health and Science University},
year = {2024},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Oregon Health and Science University 2025
Open access · US-GOV
Safety, Tolerability, and Pharmacokinetics of an Oral Withania Somnifera Product in Older Adults
New England Journal of Medicine 2024
Preprint · OA
Frailty in Older Adults
University of South Carolina 2022
Open access · US-GOV
Developing a Trauma-focused Intervention for Older Adults Living With HIV
University of Virginia 1998
Open access · US-GOV
Effects of an Oral GH Secretagogue (MK-677) on Body Composition and Functional Ability of Older Adults
Shenzhen Kangtai Biological Products Co., LTD 2021
Open access · US-GOV
A Multi-national, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of SARS-CoV-2 Vaccine (Vero Cells), Inactivated for the Prevention of COVID-19 in Healthy Adults Aged 18 Years and Older
University of Valencia 2018
Open access · US-GOV